文献速递肝病

肝硬化患者的医疗费用

Cost of Care for Patients With Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2023-08-10

该回顾性队列研究纳入2011至2015年退伍军人医疗系统内39361例肝硬化患者与138964例性别年龄匹配对照,随访至2019年。肝硬化患者第一年调整后增量费用为35029美元(95%CI 32473-37585),后续三年为14216至17629美元;并发症占超额费用大部分,多病共存者费用最高。

要点

  • 肝硬化患者第一年增量调整费用为35029美元,后续三年为14216至17629美元。
  • 肝性脑病第一年费用50080美元,腹水50364美元,高于静脉曲张20488美元和肝细胞癌37639美元。
  • 急性肾损伤或多病共存患者第一年费用最高,分别为64413美元和66653美元。

核心结论

  • 肝硬化患者医疗费用显著高于匹配对照,多病共存患者费用更高,并发症占超额费用大部分,预防并发症对节省费用潜力最大。

研究设计与样本

  • 回顾性队列研究,纳入2011至2015年退伍军人医疗系统内肝硬化患者39361例,匹配无肝硬化对照138964例,随访至2019年。

主要发现

  • 肝硬化患者第一年增量调整费用为35029美元(95%CI 32473-37585),后续三年为14216至17629美元。
  • 肝性脑病第一年费用50080美元,腹水50364美元,静脉曲张20488美元,肝细胞癌37639美元。
  • 急性肾损伤患者第一年费用64413美元,多病共存患者66653美元。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There are limited longitudinal data on the cost of treating patients with cirrhosis, which hampers value-based improvement initiatives. METHODS: We conducted a retrospective cohort study of patients with cirrhosis seen in the Veterans Affairs health care system from 2011 to 2015. Patients were followed up through 2019. We identified a sex-matched and age-matched control cohort without cirrhosis. We estimated incremental annual health care costs attributable to cirrhosis for 4 years overall and in subgroups based on severity (compensated, decompensated), cirrhosis complications (ascites, encephalopathy, varices, hepatocellular cancer, acute kidney injury), and comorbidity (Deyo index). RESULTS: We compared 39,361 patients with cirrhosis with 138,964 controls. The incremental adjusted costs for caring of patients with cirrhosis were $35,029 (95% confidence interval $32,473-$37,585) during the first year and ranged from $14,216 to $17,629 in the subsequent 3 years. Cirrhosis complications accounted for most of these costs. Costs of managing patients with hepatic encephalopathy (year 1 cost, $50,080) or ascites ($50,364) were higher than the costs of managing patients with varices ($20,488) or hepatocellular cancer ($37,639) in the first year. Patients with acute kidney injury or those who had multimorbidity were the most costly at $64,413 and $66,653 in the first year, respectively. DISCUSSION: Patients with cirrhosis had substantially higher health care costs than matched controls and multimorbid patients had even higher costs. Cirrhosis complications accounted for most of the excess cost, so preventing complications has the largest potential for cost saving and could serve as targets for improvement.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kanwal F, Nelson R, Liu Y, et al. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2023. PMID: 37561079. doi:10.14309/ajg.0000000000002472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。